Welcome to our dedicated page for Civeo Cda SEC filings (Ticker: CVEO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Civeo Corporation filings document the formal public record for a hospitality services provider serving natural resource regions in Australia and the Canadian oil sands. Its Form 8-K reports furnish quarterly and annual operating results, segment performance, adjusted EBITDA measures, share repurchase activity, investor presentations and material agreements tied to the company's revolving credit facilities.
CVEO proxy and current-report filings also cover board composition, director retirements and appointments, committee assignments, shareholder meeting proposals, executive compensation and cooperation-agreement governance terms. Credit-agreement disclosures describe borrowing subsidiaries, senior secured revolving facility commitments, interest-rate mechanics, maturity dates, leverage-based pricing and related capital-structure obligations.
NAVARRE RICHARD A reported acquisition or exercise transactions in this Form 4 filing.
Civeo Corp director Richard A. Navarre received an equity grant of 1,232 common shares as part of his annual retainer for serving as Chairman of the Board. The award was made at no cash cost per share and is structured as restricted common shares.
According to the disclosure, these restricted shares vest on the earlier of one year from May 27, 2026 or the date of the next annual shareholders' meeting. Following this grant, Navarre directly holds a total of 71,559 Civeo common shares.
NAVARRE RICHARD A reported acquisition or exercise transactions in this Form 4 filing.
Civeo Corp director Richard A. Navarre received a grant of 3,624 Common Shares as a restricted share award. The award was granted at no cash cost per share and increases his direct holdings to 70,327 Common Shares. According to the award terms, these restricted shares vest on the earlier of one year from May 27, 2026 or the date of Civeo’s next annual shareholders' meeting.
BLANKENSHIP C RONALD reported acquisition or exercise transactions in this Form 4 filing.
Civeo Corp director C. Ronald Blankenship received a grant of 3,624 restricted common shares as equity compensation. The award carries no purchase price and was granted under the Amended and Restated 2014 Equity Participation Plan of Civeo Corporation. According to the footnote, these restricted shares vest on the earlier of one year from May 27, 2026 or the next annual shareholders' meeting date. Following this award, Blankenship directly holds 54,446 common shares.
Scofield Jeffrey reported acquisition or exercise transactions in this Form 4 filing.
Civeo Corp director Jeffrey Scofield received a grant of 3,624 Common Shares as a restricted common share award. The award was granted at a price of $0.00 per share under Civeo’s Amended and Restated 2014 Equity Participation Plan.
According to the award terms, these restricted common shares vest on the earlier of one year from May 27, 2026 or the date of the next annual shareholders' meeting. After this grant, Scofield directly holds a total of 9,242 Common Shares.
Silvers Daniel B. reported acquisition or exercise transactions in this Form 4 filing.
Civeo Corp director Daniel B. Silvers received a grant of 3,624 deferred shares of the company. These shares were awarded at a stated price of $0.00 per share as equity compensation. The award was made under Civeo’s Amended and Restated 2014 Equity Participation Plan.
According to the terms, the deferred shares vest on the earlier of one year from May 27, 2026 or the next annual shareholders' meeting date. Following this award, Silvers holds 3,624 deferred shares directly.
Wall Timothy O reported acquisition or exercise transactions in this Form 4 filing.
Civeo Corp director Timothy O. Wall received a grant of 3,624 common shares as equity compensation. The award is a restricted common share grant under the Amended and Restated 2014 Equity Participation Plan of Civeo Corporation and carries no cash purchase price. These restricted shares vest on the earlier of one year from May 27, 2026 or the next annual shareholders' meeting date. Following this award, Wall directly holds a total of 21,813 common shares.
LAMBERT MARTIN reported acquisition or exercise transactions in this Form 4 filing.
Civeo Corp director Martin Lambert reported receiving a grant of 3,624 restricted common shares of Civeo Corporation at no purchase price under the Amended and Restated 2014 Equity Participation Plan. These shares vest on the earlier of one year from May 27, 2026 or the next annual shareholders' meeting date. Following this award, Lambert directly holds 40,060 common shares.
MOORE CONSTANCE B reported acquisition or exercise transactions in this Form 4 filing.
Civeo Corp director Constance B. Moore received a grant of 3,624 common shares as a restricted share award. The award was granted at a stated price of $0 per share under Civeo’s Amended and Restated 2014 Equity Participation Plan, increasing her direct holdings to 49,983 common shares.
The restricted common share award will vest on the earlier of one year from May 27, 2026 or the date of Civeo’s next annual shareholders’ meeting, linking the compensation to continued board service over that period.
Montelongo Michael reported acquisition or exercise transactions in this Form 4 filing.
Civeo Corp director Michael Montelongo received a grant of 3,624 Deferred Shares as equity compensation. The award was made at a stated price of $0.00 per share and increased his directly held Deferred Shares to 25,522 following the transaction. According to the accompanying note, the Deferred Shares were granted under Civeo’s Amended and Restated 2014 Equity Participation Plan and vest on the earlier of one year from May 27, 2026 or the next annual shareholders' meeting date.
Civeo Corporation reported the results of its 2026 Annual General Meeting of Shareholders. Shareholders elected six directors across Class II and Class III, with each nominee receiving more than 8.29 million votes in favor.
They also approved, on an advisory basis, the compensation of the named executive officers and approved an amendment to the 2014 Equity Participation Plan to increase the number of shares available for issuance by 520,920 shares, subject to adjustment under the plan. In addition, shareholders ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026.